Aarey Drugs & Pharmaceuticals Approves 36th AGM Notice and FY26 Annual Report
Aarey Drugs & Pharmaceuticals Ltd 路 Outcome 路 06 Sept 2026, 1:33 am
Aarey Drugs & Pharmaceuticals Approves 36th AGM Notice and FY26 Annual Report Aarey Drugs & Pharmaceuticals announced that its Board of Directors approved the draft Board Report, FY26 Annual Report, and the notice convening the company's 36th Annual General Meeting (AGM). The AGM is scheduled for 30th Sep'26 at 3:00 PM IST via Video Conferencing/OAVM. Additionally, the Board approved the book closure dates, cut-off date for e-voting, and appointed Practicing Company Secretary Virendra G. Bhatt (COP No. 124) as the scrutinizer for the AGM e-voting process.
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- Statement of deviation and variation for the quarter ended September 30, 2026 路 15 Nov 2026
- As per attachment 路 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... 路 15 Nov 2026
- Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve This is to intimate .... 路 14 Nov 2026
- Revised outcome 路 07 Oct 2026
